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Abstract 
Low molecular weight (LMW) peptides, derived from the breakdown of the major eye lens proteins, the 
crystallins, accumulate in the human lens with age. These LMW peptides are associated with age-related 
lens opacity and cataract, with some shown to inhibit the chaperone activity of α-crystallin. However, the 
mechanism(s) giving rise to the production of these peptides, as well as their distribution within the lens, 
are not well understood. In this study, we have mapped the distribution of these crystallin-derived 
peptides present in human lenses of different ages using matrix-assisted laser desorption/ionization-
imaging mass spectrometry (MALDI-IMS). Our data showed that most of these LMW peptides emerge in 
the lens at early middle-age, with peptides greater than 1778 Da in mass being confined to the water 
insoluble fractions, and to a lesser extent the water soluble fractions of older lenses. MALDI-IMS analyses 
showed that four peptides, derived from αA-, αB- and γS crystallins, were confined to the lens nuclear 
fibre cells upon emergence during early middle-age, but were present in both the cortex and nucleus of 
old lenses. In contrast, another major peptide, derived from the C-terminal breakdown of βA3-crystallin, 
was present in the cortical and nuclear regions of both young and old lenses. A comparison between age-
matched cataractous and non-cataractous lenses showed no distinct differences in LMW peptide profiles, 
indicating that although cataract may be a potential consequence caused by the emergence of these 
peptides, it does not contribute directly to the peptide-generating process. 
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Low molecular weight (LMW) peptides, derived from the breakdown of the major 
eye lens proteins, the crystallins, accumulate in the human lens with age. These LMW 
peptides are associated with age-related lens opacity and cataract, with some shown to 
inhibit the chaperone activity of α-crystallin. However, the mechanism(s) giving rise 
to the production of these peptides, as well as their distribution within the lens, are not 
well understood. In this study, we have mapped the distribution of these 
crystallin-derived peptides present in human lenses of different ages using 
matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS). 
Our data showed that most of these LMW peptides emerge in the lens at early 
middle-age, with peptides greater than 1778 Da in mass being confined to the water 
insoluble fractions, and to a lesser extent the water soluble fractions of older lenses. 
MALDI-IMS analyses showed that four peptides, derived from αA-, αB- and 
γS-crystallins, were confined to the lens nuclear fibre cells upon emergence during 
early middle-age, but were present in both the cortex and nucleus of old lenses. In 
contrast, another major peptide, derived from the C-terminal breakdown of 
βA3-crystallin, was present in the cortical and nuclear regions of both young and old 
lenses. A comparison between age-matched cataractous and non-cataractous lenses 
showed no distinct differences in LMW peptide profiles, indicating that although 
cataract may be a potential consequence caused by the emergence of these peptides, it 
does not contribute directly to the peptide-generating process. 
 
 




Human lens fibre cells contain high concentrations of structural proteins known as α-, 
β- and γ-crystallins. α-Crystallin, which is composed of the subunits of αA- and 
αB-crystallin, also acts as a molecular chaperone to suppress protein unfolding in the 
lens (Horwitz, 1992; Rao et al., 1995). During aging, the lens undergoes negligible 
protein turnover and, consequently, the crystallins become increasingly modified. 
These age-related modifications include truncation, oxidation, glycation, deamidation 
and phosphorylation, amongst others (Hanson et al., 2000; Aquilina and Truscott, 
2002; Harrington et al., 2004, 2007; Srivastava et al., 2004; Truscott, 2005; Wilmarth 
et al., 2006). Whilst certain structural changes appear to be associated with the normal 
maturation process of the lens, improper or unregulated modifications have been 
associated with lens opacity (Truscott et al., 1990; Truscott, 2005). 
 
Crystallin breakdown increases significantly in aged lenses and with the onset of 
cataract (Harrington et al., 2004, 2007; Srivastava et al., 2004). For example, 
crystallin fragments (peptides) have been found in both water soluble (WS) and water 
insoluble (WI) fractions of the lens, with the prevalence of these fragments in the WI 
fraction increasing with age (Srivastava et al., 1996; Lampi et al., 1998; Harrington et 
al., 2007). Recently, low molecular weight (LMW) peptides derived from the 
breakdown of crystallins have been identified in young, old and cataractous lenses 
(Santhoshkumar et al., 2008). Interestingly, a number of these endogenous LMW 
peptides appeared to be confined to a certain age group (young or old lenses), whilst 
some were present exclusively in cataractous lenses. As there is very little protease 
activity in older lenses (David and Shearer, 1989), the mechanism(s) underlying this 
crystallin breakdown remain unclear.  
 
The emergence of LMW peptides is potentially a key event in lens aging and may be 
responsible for the increase in protein aggregation and WI proteins in aged and 
cataractous lenses. For example, the LMW peptides present in aged lenses, αB1-18 and 
βA3/A159-74, have been shown to diminish the chaperone activity of α-crystallin 
(Santhoshkumar et al., 2008). In the lens, this can lead to increased protein 
aggregation and light scattering - key events in the development of age-related nuclear 
cataract (Rao et al., 1995; Truscott, 2005; Harrington et al., 2007). Furthermore, the 
cleavage mechanism(s) responsible for these LMW peptides are likely to compromise 
crystallin structure, further contributing to protein aggregation and a reduction in the 
chaperone efficacy of α-crystallin (Sharma et al., 2000; Bhattacharyya et al., 2006).  
 
  
Despite recent reports on the presence of LMW peptides in the human lens 
(Santhoshkumar et al., 2008; Sharma and Santhoshkumar, 2009), the emergence and 
distribution of these peptides during the aging process have not been investigated. 
Matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS) 
has proven to be a reliable technique for studying the distribution of proteins/peptides 
in tissue sections (Caprioli et al., 1997). Recent studies using MALDI-IMS on lens 
tissue have demonstrated that mapping and quantification of native and modified 
crystallins in the lens is possible (Han and Schey, 2006; Grey and Schey, 2009; 
Sharma and Santhoshkumar, 2009). In the present study, we have examined the 
localization of LMW crystallin peptides in the WS and WI fractions of both the 
cortical and nuclear regions of human lenses of different ages. Furthermore, we have 
used MALDI-IMS to map the emergence and distribution with age of the major LMW 
crystallin peptides in the human lens. 
  
2. Material and methods 
2. 1 Lens protein extraction and isolation of LMW crystallin peptides 
Human lenses were obtained from donors at the Lions New South Wales Eye Bank 
(Sydney, Australia) and stored immediately at -80 °C. Lenses were dissected into 
cortical and nuclear regions using a 5 mm trephine. Tissue from respective regions 
was separately homogenized in buffer A (20 mM Tris-HCl, 20 mM NaCl, 1 mM 
EDTA, pH 7.4) with a hand-held tissue homogenizer, using 1 ml of buffer per 100 mg 
tissue (wet weight), and incubated at room temperature for 15 min. The homogenates 
were centrifuged at 10,000 g for 30 min at 4 °C, and the pellets were re-homogenized 
with Buffer A and centrifuged at 10,000 g. The supernatants from both extraction 
steps were pooled together as WS protein extracts. Remaining pellets were 
re-homogenized in buffer B (8 M urea in buffer A), incubated at room temperature for 
15 min, then centrifuged at 10,000 g for 30 min at 4 °C. The supernatants were 
collected to give the water insoluble-urea soluble (WI-US) protein extracts. The urea 
concentration in all samples was adjusted to 4 M using buffer B for WS extracts and 
buffer A for WI-US extracts. β-Mercaptoethanol (0.5% v/v final concentration) was 
added and the samples were incubated at room temperature for 30 min, before being 
filtered through a 10 kDa molecular weight cut-off YM-10 Microcon centrifugal filter 
unit (Millipore, Billerica, Massachusetts, USA) by centrifugation at 8,000 g, 4 °C. 
Protease inhibitor cocktail (P2714, Sigma-Aldrich, St. Louis, Missouri, USA) was 
prepared as per the manufacturers specifications and used in all buffers. 
 
2.2 MALDI-MS and nanoLC-ESI-MS/MS peptide identification 
Peptides present in the WS and WI-US protein extracts were concentrated using C18 
Ziptips (Millipore), and spotted directly onto a MALDI plate by eluting the peptides 
with α-cyano-4-hydroxycinnamic acid matrix. MALDI-MS analysis was performed 
using a Shimadzu Axima TOF2 MALDI mass spectrometer (Save Sight Institute, 
Sydney, Australia). The LMW peptides present in the lens extracts were identified 
using nanoflow liquid chromatography electrospray-ionization (nanoLC-ESI) MS/MS 
analysis at the Australian Proteome Analysis Facility (Macquarie University, Sydney, 
Australia). Urea was removed from the extracts using C4 ZipTips (Omix, Redwood 
City, California, USA) prior to freeze-drying and loading onto an Agilent 1100 
nanoLC system (Agilent Technologies, Forest Hill, Australia) fitted with a peptide 
Captrap (Michrom Bioresources, Auburn, California, USA) and a 150 μm x 100 mm, 
300 Å C18 Protecol column (SGE Analytical Science, Ringwood, Australia), coupled 
to a Qstar XL ESI mass spectrometer (AB Sciex, Mt Waverly, Australia). Peptides 
were separated using gradient elution from 5% solvent B (90% acetonitrile, 0.1% 
formic acid) to 40% solvent B in 40 minutes, at a flow-rate of 500 nl/min (solvent A, 
  
0.1% formic acid). Peptides eluting from the column were analysed directly in 
nanoLC-ESI-MS/MS IDA scan mode. MS/MS results were searched against protein 
sequences published on Swissprot through the Mascot search engine (peptide scores > 
37 considered significant). 
 
2.3 Tissue preparation and MALDI tissue imaging 
Frozen lenses were sectioned equatorially into 20 μm thick tissue sections with 
disposable blades at -20 °C, in a Shandon Cryotome E Cryostat (Thermo Electron 
Corporation, Waltham, Massachusetts, USA). Lens sections were immediately 
thaw-mounted onto a Shimadzu MALDI-plate (TO-487, Shimadzu, Kyoto, Japan). 
Lens sections were air-dried at room temperature, before being washed consecutively 
with 30%, 50% and 70% ethanol for a period of 60 seconds each, allowing air-drying 
in between washes. This method of ethanol-washing removes physiological salts and 
lipids that would otherwise mask the ion signals of the peptides of interest. Plates 
were then sprayed with a solution of 20 mg/ml sinapic acid (Fluka, St. Louis, 
Missouri, USA) in 50% acetonitrile. Hand spraying was performed in an open-faced 
box using a Preval Spray compressed gas device (Precision Valve Corp., New York, 
USA). Sections were coated 8 times in a dual pass process from a distance of 40 cm, 
and aiming the spray plume 15 cm above the sample plates. A total volume of 30 ml 
of matrix solution was used in the coating process. Air-drying between coats was 
allowed to occur for a period of 5 min. MALDI-IMS was performed in linear mode on 
a Shimadzu Confidence MALDI-TOF mass spectrometer (Australian Institute for 
Innovative Materials, University of Wollongong). Effective laser power of 80 V was 
used for all imaging with a TV raster function (50 shots per raster position) set at 200 
μm intervals across a 100 mm2 area, sufficient to cover entire sections. Total number 
of data points per tissue section was 2601. Data was exported into BioMAP 3.7.5.5 
functional image analysis software (Novartis Institutes for Biomedical Research, 






3.1 Distribution of LMW crystallin peptides in WS and WI-US extracts of human 
lenses of different ages 
We have examined a broad age range of human lenses in an attempt to determine at 
what stage of life, and in which lens regions, the crystallin-derived LMW peptides are 
distributed. Figure 1 illustrates the MALDI-MS spectra obtained for each of the 
extracts from a 65 year old lens. Peptides which gave rise to most of the major peaks 
observed in figure 1 were separated, sequenced and identified using a 
nanoLC-ESI-MS/MS approach in conjunction with Mascot database searching 
(Supplementary Fig. S1-S4; Table S1-S4). Species of primary interest in this study 
were those that have previously been shown to possess anti-chaperone properties 
(Santhoshkumar et al., 2008), were found to increase in ion intensity with age, or were 
major peptides in the WI-US fractions. The WS fractions of a 65 year old lens (Fig. 
1A and B) were found to have peptides derived predominantly from αA- and 
αB-crystallin, along with an N-terminal peptide from γS-crystallin (residues 2-22), a 
βB1 peptide (residues 238-247) and two βB2 peptides (residues 169-180 and 91-102). 
Peptides extracted using urea included two N-terminal peptides of αB-crystallin 
(residues 1(2)-18) and a trio of βA3 peptides (Fig. 1C).  
 
Table 1 presents a summary of the distribution of LMW crystallin peptides detected in 
the WS and WI-US extracts from the cortical and nuclear regions of lenses ranging in 
age from 20 to 86 years. Peptides up to 1730 Da in mass were, on the whole, found in 
both the WS and WI-US extracts of a broad lens age range, with some being confined 
exclusively to the WS extracts. Interestingly, the γS167-178 and αA37-49 peptides were 
found across a broad age range in the nucleus water soluble (NWS) and also in the 
cortex and nucleus WI-US extracts of some age groups. The absence of these peptides 
in the cortex water soluble (CWS) fraction suggests that the molecular environments 
of the cortex and nucleus are sufficiently distinct in the human lens such that the 
nucleus renders this peptide more soluble than the cortex. Peptides greater than 1778 
Da in mass were confined predominantly to the WI-US lens extracts and, to a lesser 
extent, the WS of old lenses. The N-terminal peptides of αB-crystallin (residues 
1(2)-18) and C-terminal peptides of βA3-crystallin were isolated exclusively from the 
WI-US fractions. These peptides were found to be present in the WI-US fractions of 
lenses above 35 years, but not in the 20 year lens. Interestingly, even though 
deamidation has been mapped to residues on peptides αA2-12(13), γS2-22, and the βA3 
C-terminus peptides (Wilmarth et al., 2006), no such modification was observed. 
 
  
3.2 MALDI-IMS mapping of LMW crystallin peptides across tissue sections of human 
lenses of different ages 
Having established that crystallin-derived peptides vary greatly in solubility and gross 
distribution with age, we attempted to use MALDI-IMS to more accurately map the 
distributions of anti-chaperone peptides, peptides that were found to increase in ion 
intensity and/or area of distribution with age, and those present in the WI-US fractions. 
Lens sections were thoroughly washed in order to remove lipids and salts, as well as 
the WS proteins and peptides, in an effort to identify peptides in the WI fractions. 
Figure 2 represents the summed mass spectra, acquired at 200 μm intervals across 
lens tissue sections, for a 37 year (Fig. 2A) and an 80 year (Fig. 2B) old lens. In the 
younger lens, the major species were the C-terminal βA3 peptides at m/z3197, 
m/z3253 and m/z3390, suggesting that these peptides are the first to accumulate in the 
WI-US component with age. This is in agreement with the detection of these peptides 
in the cortex water insoluble-urea soluble (CWI-US) and nucleus water insoluble-urea 
soluble (NWI-US) fractions of lenses older than 20 years (Table 1). In contrast to this, 
MALDI-IMS analysis of an 80 year lens section revealed further significant peaks at 
m/z2187, m/z2359 and m/z2598, corresponding to N-terminal peptides of αB- and 
γS-crystallins. A fourth, small peak, which matched our lens extract data 
corresponding to the αA66-80-H2O peptide was noted at m/z1848. Along with the major 
βA3 peptide at m/z3253, these ions, indicated by an asterisk (Fig. 2B), were mapped 
in MALDI-IMS experiments performed across a broad lens age range (Fig. 3). 
 
Images from a 37 year lens revealed that the βA3189-215 peptide was the only 
significant ion detected at this age (Fig. 3). At 42 years, this ion was equally abundant, 
and additionally, signal arising from the αA, αB and γS peptides were shown to be 
emergent in the nuclear region of the lens. By 58 years, a high abundance of the 
αB2-18 peptide was evident in the nuclear region of the lens, with further less dramatic 
increases of the other peptides. By age 80, all peptides were clearly detected in both 
cortex and nucleus. The N-terminal αB peptides displayed a dramatic expansion into 
the cortical region in this transition to old age, a pattern that was also evident for the 
αA66-80 and γS2-22 peptides. The βA3189-215 peptide appeared to be distributed 
throughout the lens cross-section at ages 37 years and above. The oldest lens analysed 
was 86 years, which also was the only lens to display nuclear opacification consistent 
with age-related cataract. This lens had a significant increase in the prevalence of the 
αA66-80-H2O peptide compared with the other peptides, which showed only 
incremental expansion towards the periphery of this larger lens. Another feature of 
this lens was the apparent bias in the distribution of all peptides towards one 
hemisphere of the equatorial section, however, as the superior-inferior orientation of 
  
lenses was not noted prior to sectioning, it is difficult to make any assumptions 
regarding this bias. 
 
3.3 Determining the effect of cataract on the genesis and abundance of LMW 
crystallin peptides 
In order to assess the impact of cataractogenesis upon the apparent abundance and 
distribution of LMW peptides, spectra were acquired across the sections from a 69 
year healthy lens (Fig. 4A) and a 62 year lens which displayed opacity consistent with 
age-related nuclear cataract (Fig. 4B). The healthy lens contained each of the peptides 
previously described and are labelled accordingly. Interestingly, there were no major 
distinctions in the species of peptides present in the lenses. Taken together with the 
imaging data (Fig. 3), we conclude that cataract per se is not symptomatic of dramatic 
changes in the abundance of these LMW peptides. 
  
4. Discussion 
In this study we have examined the LMW peptides in the WS and WI-US extracts of 
human lens cortices and nuclei. Our results complement those of a recent study by 
Grey and Schey (2009), who reported the distributions of α-crystallin subunits and 
N-terminal peptides with m/z values greater than 4000 in human lenses over a broad 
age range. In the present study, peptides greater than m/z4000 were not detected, 
indicating that our use of lower percentage ethanol solutions to wash the tissue 
sections may have removed these larger peptides. The trend observed by Grey and 
Schey (2009) that crystallin truncation increases with age, in particular during the 
middle-age, and that the products are degraded progressively to low mass peptides is 
in good agreement with our findings. 
 
Our results showed that peptides greater than 1778 Da were isolated predominantly 
from the WI-US extracts of lenses 35 years and older. This implies that either the 
solubility of these peptides in aqueous buffer is low, or that they are bound to WI 
protein complexes, cytoskeleton or lens fibre cell membranes. These peptides were 
found to originate from the chaperone binding region of αA-crystallin (Sharma et al., 
2000), the N-terminus of αB- and γS-crystallins and the C-terminus of βA3-crystallin. 
The N-terminal peptides of αB-crystallin have been shown to significantly reduce the 
molecular chaperone function of α-crystallin oligomers (Santhoshkumar et al., 2008). 
In situ mapping of the αB peptides revealed that αB2-18 was densely localized to the 
nucleus of a 58 year lens, with αB1-18 showing similar distribution but lower ion 
density. This dramatic increase in the αB1(2)-18 peptides in the nucleus during 
middle-age and their subsequent emergence in the cortex of old lenses may well 
facilitate aggregation of crystallins in vivo, particularly if their in vitro demonstrated 
anti-chaperone properties apply to the crowded environment of the lens.  
. 
It has been suggested that the interaction of lenticular α-crystallin with anti-chaperone 
peptides could be a key event in protein aggregation and the development of cataract 
during aging (Santhoshkumar et al., 2008). The extended periods that these LMW 
peptides remain in the lens indicate that the lens may be unable to efficiently degrade 
them, which can lead to unregulated accumulation of these peptides with age. These 
peptides emerge in the lens (~35-42 years in our study) during a period which also 
sees a drastic increase in WI proteins and crystallin truncation (Harrington et al., 2004; 
Srivastava et al., 2004), an increase in membrane associated lens proteins (Friedrich 
and Truscott, 2009) and the onset of a barrier to diffusion at the nucleo-cortical 
interface in the lens (Sweeney and Truscott, 1998). Taken together, the early 
middle-age is potentially an important period in lens aging, during which crystallins 
  
in the lens nucleus become extensively structurally modified and truncated. The 
structural damage arising from the cleavage of these proteins may also result in the 
loss of the proteins’ normal function, including the molecular chaperone function of 
α-crystallin, particularly if the cleavages occur at the chaperone site sequence (e.g. the 
αA66(67)-75, αA66-80 and αA69-80 peptides). 
 
In addition, we have investigated the possibility that the production of these LMW 
peptides in the lens may be a direct causative factor in cataractogenesis by comparing 
age-matched healthy and cataractous lenses. Our data revealed no significant 
differences in the abundance of LMW crystallin peptides, indicating that the changes 
to the lens environment caused by cataract formation do not contribute directly to the 
peptide-generating process. This result corresponds to a similar observation on the 
effect of cataract formation had on crystallin truncation (Grey and Schey, 2009). 
 
Although we have clearly demonstrated that these LMW peptides are present in 
human lenses, and that their distributions are dependent on age and solubility, the 
mechanisms leading to peptide cleavage from the intact crystallins is not understood. 
Interestingly, when examining the peptide sequences, we noticed that the majority of 
these LMW peptides began with an Asp (αA67-75(80), αA69-80, αA2-12(13), αB2-18), Ser 
(γS2-22), or even a Ser-Asp (αA66-75(80)), Ser-Pro (αB45-54(57), γS167-178) combination. 
Moreover, the sequences of a number of peptides were followed immediately by an 
Asp (αA66(67)-75) or Asp-Ser (βB291-102), Ser-Pro (αA66(67)(69)-80, αB1(2)-18) and Pro-Ser 
(αB45-57) combination. Also, the last residue of the γS2-22 peptide is an Asp, the last 
residue of the αA150-160, αB28-39 and βB2169-180 peptides is a Pro, and the αA43-56 
peptide is preceded by a Ser. Spontaneous peptide bond cleavage via imide ring 
formation at labile Asp residues has previously been reported in bovine α-crystallins 
(Geiger and Clarke, 1987; Voorter et al., 1988). Asp residues are known to be 
intrinsically unstable, thus they are common sites of post-translational modifications 
(Voorter et al., 1988; Robinson and Robinson, 2004). This may explain the large 
number of LMW crystallin peptides cleaved at Asp residues.  
 
The frequency of Ser, Pro and their dipeptide combinations either at the beginning of 
the observed peptide sequences, or immediately following in the corresponding 
crystallin sequence, is also suggestive of a chemical or enzymatic cleavage 
mechanism at these sites. While it is known that proline-directed kinases favour 
phosphorylation of Ser-Pro (Aitken et al., 1995) and similar cleavage patterns have 
been reported from both bovine and human αA-crystallin (Van Kleef et al., 1975; 
Takemoto, 1995), it is not known if this motif is recognized by proteases. A sequence 
  
pattern also emerges when looking at the penultimate two residues of the αA66(67)(69)-80 
and αB1(2)-18 peptides and the two residues preceding the βA3189-215 peptide. The 
dipeptides are His-Phe, Phe-His, and His-His, respectively, each motif then contains 
consecutive aromatic residues. As calpains, the primary proteases in the human lens, 
are known to cleave after consecutive aromatic residues (Cuerrier et al., 2005), this 
may suggest a role for lens-based calpains in these particular instances. Furthermore, 
tertiary structural elements rather than primary amino acid sequences are likely 
responsible for directing the cleavage of protein substrates by calpains (Cuerrier et al., 
2005), which may explain the high degree of specificity that we have observed for the 
αA, αB and βA3 peptides. However, the activity of calpain in the primate lens has 
been reported to be largely inhibited by high levels of the endogenous calpain 
inhibitor - calpastatin (David et al., 1989; Nakajima et al., 2006), indicating that other 
mechanisms may be responsible for these cleavages. 
 
At present, there appears to be no clear evidence linking calpains and other lenticular 
proteases (Swanson et al., 1981, 1985; David and Shearer, 1989; Wride et al., 2006) 
with these crystallin cleavages. The absence of significant proteolytic activity in adult 
lenses suggests that these LMW peptides may be generated through nonenzymatic 
cleavage of crystallins. Whilst the mechanisms are not fully understood, lens proteins 
(such as aquaporins) have been shown to undergo chemical cleavage with age (Ball et 
al., 2004; Korlimbinis et al., 2009). Age-dependent changes in the lens, such as the 
formation of a barrier at the nucleo-cortical interface (Sweeney and Truscott, 1998), 
may encourage peptide cleavages, as they induce changes to the chemical 
environment of the lens nucleus. In addition, lens nuclear fibre cells are older, have a 
slightly acidic environment (Bassnett and Duncan, 1985) and are more susceptible to 
oxidative-damage compared to cortex fibre cells (Sweeney and Truscott, 1998; 
Truscott, 2005) - characteristics that may all favour chemical cleavages.  
 
In conclusion, the data presented in this study is the first to examine the distribution 
and localization of LMW crystallin peptides in the aging human lens using 
MALDI-IMS. The timing and the nucleus-to-cortex emergence pattern of these LMW 
peptides suggests that they may have a significant impact on the later development of 
the human lens. 
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Figure 1: MALDI-TOF MS spectra of the LMW crystallin peptides present in the 
CWS (A), NWS (B), CWI-US (C) and NWI-US (D) extracts of a 65 year old human 
lens. Peak ions and the peptide sequence origins of the major peaks are labelled. 
 
Figure 2: Summed mass spectra, acquired at 200 μm intervals across lens tissue 
sections, for a 37 year (A) and an 80 year (B) old lens. In the younger lens, the major 
species were the C-terminal βA3 peptides at m/z3197, m/z3253 and m/z3390. The 80 
year lens section revealed further significant peaks at m/z2187, m/z2359 and m/z2598, 
corresponding to N-terminal peptides of αB- and γS-crystallins. Along with the major 
βA3 peptide at m/z3253 and a smaller peak at m/z1848 corresponding to the 
αA66-80-H2O peptide, these ions have been indicated by an asterisk. 
 
Figure 3: MALDI-IMS spectra mapping the peptides indicated by an asterisk in 
figure 2B. Lenses were sectioned equatorially and prepared for analysis by manual 
spray deposition of sinapic acid. Ages (20-86 years) are noted in the x-axis whereas 
peptide identities are labelled in the y-axis. Relative peptide intensities are illustrated 
using a black-red-white scale, white being of highest relative intensity. Dashed oval 
outlines indicate the edge of the tissue sections. Scale bars, 2 mm. 
 
Figure 4: Summed MALDI-MS spectra from imaging experiments performed on 
sections from a 69 year healthy lens (A) and a 62 year moderately cataractous lens 
(B). No major distinctions in the species of peptides present were observed, 
suggesting that cataract formation as such is not causative, nor symptomatic, of the 










Table 1: Distribution of LMW crystallin peptides present in the CWS, NWS, CWI-US and NWI-US extracts of 
human lenses aged between 20 and 86 years. Peptides in the lens extracts were identified using MALDI-MS 
and nanoLC-ESI-MS/MS analysis. Shaded cells indicate a positive detection (peptide ion intensity greater than 








CWS Extract NWS Extract CWI-US Extract NWI-US Extract 
Lens Age (years) Lens Age (years) Lens Age (years) Lens Age (years) 
20 35 43 65 86 20 35 43 65 86 20 35 43 65 86 20 35 43 65 86 
1069.6 βB1-(238-247)          
1152.6 αA-(67–75)          
1165.7 αB-(93-103)          
1193.6 αA-(150-160)          
1210.6 αB-(45-54)          
1239.7 αA-(66–75)          
1258.5 βB2-(169-180)          
1315.8 βB2-(91-102)          
1388.8 γS-(167–178)          
1403.7 αB-(28-39)          
1426.8 αA-(2–12)          
1448.7 αA-(57–69)          
1507.8 αA-(69-80)          
1527.8 αA-(2–13)          
1543.8 αA-(37–49)          
1550.8 αB-(45–57)          
1731.0 αA-(43–56)          
1778.9 αA-(67–80)          
1848.0 αA-(66–80)a          
1865.9 αA-(66–80)          
2187.2 αB-(2–18)          
2359.2 αB-(1–18)b          
2598.4 γS-(2–22)c          
3197.0 βA3-(190–215)          
3252.7 βA3-(189–215)          
3389.7 βA3-(188–215)          
 
a. Peptide has a loss of H2O at the D69 residue. 
b. Peptide has an acetylated-Met at the N-terminus. 
c. Peptide has an acetylated-Ser at the N-terminus. 
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